Acute Effects of Inhaled Sodium Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction

Trial Profile

Acute Effects of Inhaled Sodium Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Aug 2017

At a glance

  • Drugs Sodium nitrite (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Mar 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 01 Feb 2016 Primary endpoint 'Exercise pulmonary capillary wedge pressure' has been met, according to a Mast Therapeutics media release.
    • 04 Feb 2015 Preliminary results are expected in the third quarter of 2015, according to a Mast Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top